Arterosil, a patent-pending nutraceutical, is the only prouct in the world that has been clinically proven to rebuild the endothelial glycocalyx. Arterosil contains specialized sulfated polysaccharides (SSP) derived from a rare seaweed and are reported to possess anticoagulant and antithrombotic activity.